CAS: 1380341-99-0
Ref: AN-AG009Z01
| 5mg | 159.00 € | |
| 10mg | 145.00 € | |
| 25mg | 243.00 € | |
| 50mg | 549.00 € |
Estimated delivery in United States, on Friday 10 May 2024
Ref: 4Z-G-219002
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 17 May 2024
Ref: 4Z-G-219001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 17 May 2024
GAL-021
CAS:1380341-99-0
GAL-021 an intravenous BKCa-channel blocker.
Formula:
C11H22N6O
Purity:
99.73%
Color and Shape:
Solid
Molecular weight:
254.33
Ref: TM-T3557
| 1mg | 43.00 € | |
| 2mg | 54.00 € | |
| 5mg | 87.00 € | |
| 10mg | 130.00 € | |
| 25mg | 236.00 € | |
| 50mg | 370.00 € | |
| 100mg | 547.00 € | |
| 500mg | 1,189.00 € | |
| 1ml*10 (DMSO) | 95.00 € |
Estimated delivery in United States, on Friday 17 May 2024
N2-Methoxy-N2-methyl-N4,N6-dipropyl-1,3,5-triazine-2,4,6-triamine or ENA-001
CAS:1380341-99-0
Formula:
C11H22N6O
Molecular weight:
254.34
Ref: TR-M563780
| 250mg | 1,050.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
GAL-021
CAS:1380341-99-0
GAL-021 is an orally active compound that is being developed for the treatment of inflammatory …
Formula:
C11H22N6O
Purity:
Min. 95%
Molecular weight:
254.33 g/mol
Ref: 3D-FFC34199
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Friday 21 Jun 2024
